Orbimed Advisors - MILESTONE PHARMACEUTICALS IN ownership

MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 30 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of MILESTONE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$11,178,000
-32.6%
1,817,521
-29.7%
0.20%
-24.5%
Q1 2022$16,588,000
-2.0%
2,583,8210.0%0.27%
+23.4%
Q4 2021$16,924,000
+14.7%
2,583,8210.0%0.22%
+34.6%
Q3 2021$14,754,000
+3.8%
2,583,8210.0%0.16%
+12.5%
Q2 2021$14,211,000
-5.0%
2,583,8210.0%0.14%
+2.9%
Q1 2021$14,960,000
-10.4%
2,583,821
+3.6%
0.14%
-4.1%
Q4 2020$16,704,000
+491.5%
2,493,109
+546.2%
0.15%
+317.1%
Q3 2020$2,824,000
-51.6%
385,791
+5.9%
0.04%
-57.8%
Q4 2019$5,831,000364,2060.08%
Other shareholders
MILESTONE PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Alta Fundamental Advisers LLC 1,176,189$3,646,1861.74%
Bleichroeder LP 1,326,085$4,110,8641.01%
BML Capital Management, LLC 272,500$844,7500.78%
VR Adviser, LLC 2,208,812$6,847,3170.72%
Lion Point Capital, LP 450,207$1,395,6420.62%
PVG ASSET MANAGEMENT CORP 15,405$47,7550.32%
Affinity Asset Advisors, LLC 335,068$1,038,7110.29%
RTW INVESTMENTS, LP 3,256,102$10,093,9160.21%
Ikarian Capital, LLC 462,828$1,434,7670.17%
Boxer Capital, LLC 309,007$957,9220.05%
View complete list of MILESTONE PHARMACEUTICALS IN shareholders